Factory Supple Pure Natural Ginkgo Biloba Extract Flavonoids Ginkgolide

(1) Nomen Anglicum: Ginkgo Biloba Extract

(2) Formularium: 24/6%;24%

(3) Extraction source: Leaf of Ginkgo biloba L.

Commodum:

1) 13 annos uberis experientiae in R&D et productionis stabilitatem parametri producti obtinent;

2) C% plantarum extracta tutiora et salubriora in tuto collocant;

3) Professional R&D equos speciales solutiones et officia nativus secundum exigentias mos praebere potest;

4) Free exempla praeberi possunt.

Product Detail

(5) CAS numerus: 90045-36-6;formula hypothetica: C8H9NO4S;pondus hypotheticum: 215.226

Factus in Sinis, propriis utens rudimentis plantatis ad fructus fructus premium faciendum

Fast ducunt temporibus

IX - gradus qualitas processus imperium

Valde peritus operationes et qualitas certitudinis virgam

Stringent in domo temptationis signa

CELLA tam in USA quam in Sinis, celeriter responsum .

EXPLICATIO	SPECIFICATION	Effectus	VIA
Assay.Flavonoids.	≥24%(NLT24.0%)	24.44%	HPLC
Ginkgolide	/	6.13%	HPLC
Aspectus	Flavo-brunneis pulveris	Obsequitur	Visual
Odor	Proprium	Obsequitur	Organoleptic
Mole density ICTUS densitas Sieve analysis	NLT XCVIII% transiet LXXX mesh	Obsequitur	GB/T 5507-2008
Damnum in Siccatio	5.0%	3.48%	GB/T 14769-1993
Residere in Ignition	≤2.0%	1.21%	AOAC 942.05, 18th
Grave metallum	<10ppm	Obsequitur	USP <231>, methodus II
As	<2ppm	Obsequitur	AOAC 986.15, 18th
Pb	<1ppm	Obsequitur	AOAC 986.15, 18th
Hg	<0.5ppm	Obsequitur	AOAC 971.21, 18th
Microbiologia
Totalis comitis Plate	<10000cfu/g	Obsequitur	AOAC 990.12, 18th
Fermentum & Molds	<1000cfu/g	Obsequitur	FDA (BAM) Chapter 18, 8th Ed.
E.Coli	Negative	Obsequitur	AOAC 997.11, 18th
Salmonella	Negative	Obsequitur	FDA (BAM) Chapter 5, 8th Ed.
Stipare et at
stipare	25kgs/orum.Sarcina in papyro-tympana et duo intus sacculos plasticos.
Repono	Condite in vase bene clauso ab humore, sole, luce, seu calore.
Fasciae vita	Annis II.